APHROZONE USA, INC. Form 483 Details
Form 483Source: FDA inspection recordConfirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months.
To check this against FDA, open FDA's record for this establishment on FDA's Data Dashboard, which lists this inspection under FEI 3012056155.
APHROZONE USA, INC.
Los Angeles, California, United States
Issue DateSeptember 17, 2018
FEI Number3012056155
CountryUnited States
Status
No Warning LetterProduct Type
Drugs